Beam Therapeutics Inc.

BEAM·NasdaqGS·Healthcare
Compare
27.79+1.46 (+5.55%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close26.33
Open27.06
Day range26.2628.00
52-week range20.2338.26
Off day high−0.75%
Off 52-week high−27.37%
Volume1.35M
Avg. volume (3M)1.83M
Market cap2.88B
EPS (TTM)-0.8700
Forward P/E-5.63
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.22
Shares outstanding103.50M
Short interest39.28% of float
Earnings dateNov 3, 2026
Analyst target49.38
Profit margin−55.45%

Against its peers

Compare in full ›
BEAM PGEN SANA CRSP IONS 4591.T
Market cap 2.88B 1.81B 766.36M 5.02B 6.67B 3.39B
P/E (TTM) — — — — — —
Forward P/E -5.6 -23.0 -4.6 -14.4 -35.0 -1.1
Price/book 2.2 85.7 5.0 3.0 15.1 1.2
Dividend yield — — — — — —
1-year change +14.13% +31.58% −40.20% −12.28% −45.88% −29.21%
Today +5.55% −3.71% +4.92% +3.57% −0.67% −4.76%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Beam Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Precigen, Inc.PGEN · Biotechnology 1.81B 5.06 −3.71%
Sana Biotechnology, Inc.SANA · Biotechnology 766.36M 2.5600 +4.92%
CRISPR Therapeutics AGCRSP · Biotechnology 5.02B 51.78 +3.57%
Ionis Pharmaceuticals, Inc.IONS · Biotechnology 6.67B 40.15 −0.67%
Ribomic Inc.4591.T · Biotechnology 3.39B 60.00 −4.76%
Arcturus Therapeutics Holdings Inc.ARCT · Biotechnology 308.96M 10.87 +13.94%
Sarepta Therapeutics, Inc.SRPT · Biotechnology 2.01B 18.99 +2.43%
Design Therapeutics, Inc.DSGN · Biotechnology 665.24M 10.63 +2.80%

Also based in Cambridge, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Moderna, Inc.MRNA · Cambridge, MAOdds 103.15B 258.38 +13.11%
Biogen Inc.BIIB · Cambridge, MA 37.61B 254.46 +2.22%
Akamai Technologies, Inc.AKAM · Cambridge, MAOdds 12.35B 85.93 −0.69%
GE Vernova Inc.GEV · Cambridge, MA 220.43B 832.83 −9.30%
Alnylam Pharmaceuticals, Inc.ALNY · Cambridge, MAOdds 21.57B 161.08 +0.74%
HubSpot, Inc.HUBS · Cambridge, MA 11.09B 216.64 −4.21%
Nuvalent IncNUVL · Cambridge, MA 9.81B 123.96 0.00%
Scholar Rock Holding CorporationSRRK · Cambridge, MA 5.61B 46.09 +4.80%

The stocks whose daily moves over the past year went most closely with Beam Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
CRISPR Therapeutics AGCRSP · Correlation 0.76 5.02B 51.78 +3.57%
Intellia Therapeutics, Inc.NTLA · Correlation 0.66 1.72B 12.31 +3.79%
Editas Medicine, Inc.EDIT · Correlation 0.66 417.74M 2.7200 +4.62%
Sana Biotechnology, Inc.SANA · Correlation 0.55 766.36M 2.5600 +4.92%
Arcturus Therapeutics Holdings Inc.ARCT · Correlation 0.52 308.96M 10.87 +13.94%
Ionis Pharmaceuticals, Inc.IONS · Correlation 0.41 6.67B 40.15 −0.67%
Moderna, Inc.MRNA · Correlation 0.40Odds 103.15B 258.38 +13.11%
Arcus Biosciences, Inc.RCUS · Correlation 0.39 2.43B 19.31 +2.12%

What visitors to Beam Therapeutics's page also look at.

Company Mkt cap Price Today
Intellia Therapeutics, Inc.NTLA 1.72B 12.31 +3.79%
Editas Medicine, Inc.EDIT 417.74M 2.7200 +4.62%
Twist Bioscience CorporationTWST 9.45B 142.58 +1.63%
CRISPR Therapeutics AGCRSP 5.02B 51.78 +3.57%
Fate Therapeutics, Inc.FATE 250.42M 2.0900 +2.45%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All BEAM news ›
The Globe and Mail·

Beam Therapeutics (BEAM) Gets a Buy from Citi

Citi analyst Samantha Semenkow reiterated a Buy rating on Beam Therapeutics yesterday and set a price target of $68.00. Semenkow covers the Healthcare sector, focusing on stocks such as Cullinan Management, Argenx Se, and Nektar…

BEAMBEEM
@nature·Positive

Building the tools behind genome editing breakthroughs

CAGE uses automated liquid handling robots to facilitate high-throughput gene editing and drug screening workflows.Credit: St. Jude Children's Research Hospital CAGE director Shondra Pruett-Miller discusses the centre's role in advancing…

CRSPBEAMGOOGL
Nature·Positive

Discussions with the gene editor

Nature Reviews Chemistry (2026) Cite this article Ahead of his 45th birthday, Feng Zhang, James and Patricia Poitras Professor of Neuroscience at the Massachusetts Institute of Technology, discussed his life in science. Howard Hughes…

CRSPBEAMPRMEGOOGL

From the 4Search news index, newest first.

In the news

23mentions in 30 days
22with it in the headline
Mixedsentiment

Mentioned with

Beam Therapeutics Inc.11Beam Therapeutics Inc10U.S. District Court8Yoltech Therapeutics8Shiva Fritsche7U.S. Food and Drug Administration6Crispr Therapeutics5Eli Lilly5

People in the coverage

Emma" Wang12Jensen12Serapha11Serapha Bio11Yuxuan11Bethany J. Cavanagh9

Themes

Biotechnology15Healthcare13Biotech12SEC Filings9Gene Therapy8EPS6Therapeutics5California3

Most coverage from

  1. themarketsdaily.com5
  2. geneonline.com3
  3. defenseworld.net2
  4. investors.beamtx.com2
  5. seekingalpha.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 23 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance